Related Topics News -

     
 < Previous page   Title only   |   Print 
     
美因基因 : 黃宇峰不再擔任執董兼首席執行官

2024-01-18T  
《公司業績》美因基因半年純利3,511.7萬元人民幣升97.3%

2023-08-31T  
美因基因擬進行股份購回 上限2,392萬股

2023-07-24T  
《公司業績》美因基因全年盈轉虧蝕1,761.8萬人幣

2023-04-03T  
《盈警響號》美因基因預計全年轉虧最少1,300萬人民幣

2023-03-21T  
《公司業績》美因基因半年純利按年跌49.6%至1,780萬元人幣 不派息

2022-08-30T  
美因基因穩定價格期結束 超額配股權失效

2022-07-18T  
 < Previous page 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.